Detailed FundamentalsSingle-page fundamentals layout — broad valuation, growth, profitability, health, competitors, top funds & analyst detail.
Back to Quotes search
REGNRegeneron Pharmaceuticals Inc Live data
$930.59▲ +14.53 (1.6%)as of Nov 11, 2026, 6:05 PM UTC
Price chartUnavailable
Loading price history...
52-Week Range
Trailing twelve months
$591.52$991.73
1-Month Range
Month up 23.6%
$753.12$973.36
Daily Price Range
Day up 1.6%
$898.29$932.39
Volume
vs 853120 avg
442280853120 avg
Profile
Identity and capital structure
SectorUnclassified
IndustryCommon Stock
Market Cap$96.0B
Short % of Float—
Employees—
Sales—
Shares Outstanding103,214,090
IPO Date—
Last Reported Qtr.—
Next Qtr. Report—
Headquarters—
Homepagewww.regeneron.com
Regeneron Pharmaceuticals Inc — is a public issuer in the Vantage universe..
Warnings
1 signal
Live
- No material red flags detected in fundamental screen
Scores
0–100 · higher is better except where noted · Insider Sent: directional buy ratio (excl. gifts/grants)
Value
—
Growth
—
Quality
—
Sentiment
—
Insider Sent.
—
Piotroski F
—
Altman Z
—
Consensus rating unavailable — no analyst coverage on file for REGN.
Price targets unavailable — no 12-month targets on file for REGN.
Valuation Engine
DCF Intrinsic Valuation Model
Run an interactive 5-year Discounted Cash Flow valuation on REGN, calculate Margin of Safety, and stress-test WACC discount hurdles.
RetrievedQuote: Live · Insiders: Live · Fundamentals/Benchmarks: Curated · Vantage Composite · 1 warnings surfacedNov 11, 2026, 6:05 PM UTC